SAM ABRAHAM: Open Payments
NPI 1831349448 · RICHARDSON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,071 in 151 payments from 31 companies in 2025. Trend: 2023 $3,670 · 2024 $3,283 · 2025 $4,071
Food & beverage: $3,896Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $841 |
| Amgen Inc. | 15 | $427 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $363 |
| Novo Nordisk Inc | 11 | $258 |
| Abbott Laboratories | 3 | $257 |
| ABBVIE INC. | 13 | $201 |
| Axsome Therapeutics, Inc. | 4 | $184 |
| GlaxoSmithKline, LLC. | 13 | $177 |
| Otsuka America Pharmaceutical, Inc. | 9 | $175 |
| PFIZER INC. | 5 | $149 |
Products named: Kerendia, FARXIGA, AIRSUPRA, FREESTYLE LIBRE 3, BREZTRI, Wegovy, JARDIANCE, PROLIA.
Industry payments across TX — which companies pay providers there.
